Ophthalmic applicator displacement as a method of treating large diffuse uveal melanomas
- PMID: 37425204
- PMCID: PMC10324590
- DOI: 10.5114/jcb.2023.128920
Ophthalmic applicator displacement as a method of treating large diffuse uveal melanomas
Abstract
Purpose: The presentation of results of an ophthalmic plaque displacement as a brachytherapy treatment method of large diffuse uveal melanomas.
Material and methods: This was a retrospective analysis of treatment results of 9 patients with large diffuse uveal melanomas using ophthalmic plaque displacement. Patients were treated with this method in our center between 2012 and 2021 (last follow-up visit in 2023). To achieve appropriate radiation dose distribution for large tumors with a base greater than 18 mm, brachytherapy (106Ru in 7 patients and 125I in 2 patients) with applicator displacement was used as primary treatment. Median follow-up was 2.9 years, and for patients with positive primary treatment results, it was 1.7 months. Median time to local relapse was 2.3 years.
Results: In 5 patients, a positive result of local treatment was obtained, out of whom, one patient underwent enucleation due to complications. In the next 4 cases, local recurrence developed. In all tumors, the use of applicator displacement method caused that planning target volume (PTV) was effectively covered with treatment isodose.
Conclusions: Brachytherapy with ocular applicator displacement allows for the treatment of tumors with base measurements larger than 18 mm. The application of this method may be considered as an alternative for eye enucleation in particular cases of large diffuse tumors, such as a neoplasm of the eye with vison, or when a patient does not consent to enucleation.
Keywords: applicator displacement; brachytherapy; diffuse uveal melanoma; enucleation; ocular melanoma; ophthalmic applicator; plaque displacement; uveal melanoma.
Copyright © 2023 Termedia.
Conflict of interest statement
The authors report no conflict of interest.
Figures




References
-
- The American Brachyterapy–Ophaltamic Oncology Task Force . Society consensus guadlines for plaue brachyterapy of uveal melanoma and retinoblastoma. Brachyterapy 2014; 13: 1-14. - PubMed
-
- Muller K, Nowak PJ, de Pan Cet al. . Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2005; 63: 116-122. - PubMed
-
- Modorati G, Miserocchi E, Galli Let al. . Gamma knife radiosurgery for uveal melanoma: 12 years of experience. Br J Ophthalmol 2009; 93: 40-44. - PubMed
LinkOut - more resources
Full Text Sources